Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Deepan-Pachan: The First Line of Treatment

View through CrossRef
The science of Ayurveda is laid upon its fundamental principles and concept. Having a holistic approach its purpose are maintenance of health and elimination of disease. For the second purpose the approach for management of the disease begins with examination of patient. Classical texts have highlighted 10 important factors to be examined before reaching a diagnosis, one of those factors is Agni. The concept of Agni is variably explained in various texts, but the fundamentals remain same. The significance of Agni can be understood, as in Ashtang hriday it is mentioned that the reason behind every disease is the weakness of this Agni. Textually as well as practically, it is seen that pathogenesis of every disease begins with weakness of Agni. Weakened Agni leads to formation of Aama which is the undigested Ahara rasa, the root cause of diseases. While the pathogenesis of diseases begins with these two steps the therapeutics will also include management of these two as a priority. Weakened Agni is managed by Deepan karma whereas Aama is managed by Pachan karma. These two Karmas form the first line of treatment in managing various disorders mostly those involving Aama dosha. Both of these karmas can be used in various stages depending upon requirement whether solely or in combination. This article attempts to highlight the significance of Deepan and Pachan karma thereby highlighting the importance of Agni in therapeutics.
Title: Deepan-Pachan: The First Line of Treatment
Description:
The science of Ayurveda is laid upon its fundamental principles and concept.
Having a holistic approach its purpose are maintenance of health and elimination of disease.
For the second purpose the approach for management of the disease begins with examination of patient.
Classical texts have highlighted 10 important factors to be examined before reaching a diagnosis, one of those factors is Agni.
The concept of Agni is variably explained in various texts, but the fundamentals remain same.
The significance of Agni can be understood, as in Ashtang hriday it is mentioned that the reason behind every disease is the weakness of this Agni.
Textually as well as practically, it is seen that pathogenesis of every disease begins with weakness of Agni.
Weakened Agni leads to formation of Aama which is the undigested Ahara rasa, the root cause of diseases.
While the pathogenesis of diseases begins with these two steps the therapeutics will also include management of these two as a priority.
Weakened Agni is managed by Deepan karma whereas Aama is managed by Pachan karma.
These two Karmas form the first line of treatment in managing various disorders mostly those involving Aama dosha.
Both of these karmas can be used in various stages depending upon requirement whether solely or in combination.
This article attempts to highlight the significance of Deepan and Pachan karma thereby highlighting the importance of Agni in therapeutics.

Related Results

Ayurvedic management of Lumbar Radiculopathy w.s.r. to Katigraha specifically on Roland Morris Criteria: A Case Study
Ayurvedic management of Lumbar Radiculopathy w.s.r. to Katigraha specifically on Roland Morris Criteria: A Case Study
Low back pain affects approximately 60.85% of adults during some point of their life and 10% of this is because of lumbar radiculopathy (LR). Katigraha which is correlated with LR ...
Current therapeutic strategies for erectile function recovery after radical prostatectomy – literature review and meta-analysis
Current therapeutic strategies for erectile function recovery after radical prostatectomy – literature review and meta-analysis
Radical prostatectomy is the most commonly performed treatment option for localised prostate cancer. In the last decades the surgical technique has been improved and modified in or...
The Impact of IL28B Gene Polymorphisms on Drug Responses
The Impact of IL28B Gene Polymorphisms on Drug Responses
To achieve high therapeutic efficacy in the patient, information on pharmacokinetics, pharmacodynamics, and pharmacogenetics is required. With the development of science and techno...
PIPPALYADI TAILA ANUVASAN BASTI IN ARSHA(HEAMORRIED).
PIPPALYADI TAILA ANUVASAN BASTI IN ARSHA(HEAMORRIED).
Arsha(Haemorrhoid)is one grave disease included AshtaMahagada. According to Sushruta, vitiated VataDosha localizes in Guda Vali and vitiated Twak, Mansa, Meda and Rakta, resulting ...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract Introduction Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...
Edoxaban and Cancer-Associated Venous Thromboembolism: A Meta-analysis of Clinical Trials
Edoxaban and Cancer-Associated Venous Thromboembolism: A Meta-analysis of Clinical Trials
Abstract Introduction Cancer patients face a venous thromboembolism (VTE) risk that is up to 50 times higher compared to individuals without cancer. In 2010, direct oral anticoagul...
Supplementary Data from Targeted BiTE Expression by an Oncolytic Vector Augments Therapeutic Efficacy Against Solid Tumors
Supplementary Data from Targeted BiTE Expression by an Oncolytic Vector Augments Therapeutic Efficacy Against Solid Tumors
<p>Supplementary Methods, Supplementary Figures S1-S15 Fig. S1. Purification and binding specificity of MV-encoded BiTEs. (A) Purification of MV-expressed BiTEs. Vero cells w...
Exploring the Efficacy of Once and Twice Weekly Thyroxine Dosing: A Promising Approach for Hypothyroidism Management
Exploring the Efficacy of Once and Twice Weekly Thyroxine Dosing: A Promising Approach for Hypothyroidism Management
Abstract Introduction Hypothyroidism is a common endocrine disorder, in which the management involves daily intake of thyroxine. However, adherence to a daily medication regimen po...

Back to Top